Approximately 7 Million Shares Shorted Since March 2006 According to
BUYINS.NET Research Report
FREDERICK, Md., Feb. 12 /PRNewswire-FirstCall/ -- BioElectronics
Corporation (Pink Sheets: BIEL) announced today that BUYINS.NET,
http://www.buyins.net, is initiating coverage of BioElectronics Corporation after
releasing the latest short sale data to February 2008. From March 2006 to
February 2008 approximately 90.5 million total aggregate shares of BIEL
have traded for a total dollar value of nearly $10 million. The total
aggregate number of shares shorted in this time period is approximately 7
million shares. The BIEL SqueezeTrigger price of $0.11 is the volume
weighted average short price of all short selling in BIEL. The first of
several short squeezes is expected to begin when shares of BIEL close above
$0.04, where approximately 400,000 shares have been shorted. According to
data provided by the SEC, on September 28th, 2007 there were 133,073 shares
failing to deliver (also referred to as, naked short). To access
SqueezeTrigger Prices ahead of potential short squeezes beginning, visit
Month Total Vol. Short Vol. Avg. Price Short $ Value
March '06 3,012,387 231,954 $0.31 $71,326
April 1,677,725 129,185 $0.28 $35,849
May 3,029,656 233,284 $0.24 $55,988
June 3,567,224 274,676 $0.21 $58,012
July 2,275,528 175,216 $0.17 $28,911
August 1,822,212 140,310 $0.15 $21,397
September 4,214,438 324,512 $0.12 $38,941
October 8,519,279 655,984 $0.11 $71,502
November 4,170,822 321,153 $0.09 $29,321
December 4,649,178 357,987 $0.11 $38,305
January '07 3,320,884 255,708 $0.12 $30,174
February 3,515,165 270,668 $0.11 $29,449
March 2,782,734 214,271 $0.09 $19,284
April 3,721,879 286,585 $0.10 $27,598
May 3,418,871 263,253 $0.09 $23,166
June 1,715,340 132,081 $0.07 $8,863
July 1,907,068 146,844 $0.06 $9,016
August 3,717,437 286,243 $0.08 $24,245
September 3,213,693 247,454 $0.10 $25,042
October 3,803,891 292,900 $0.09 $26,361
November 10,134,024 780,320 $0.07 $51,345
December 7,117,414 548,041 $0.05 $27,950
January '08 4,299,638 331,072 $0.04 $13,706
February 927,365 71,407 $0.04 $3,106
Total: 90,533,852 6,971,107 $0.11 $768,857
* short volume is approximated using a proprietary algorithm.
** average short price is calculated using a volume weighted average short
*** short volume is the total short trade volume and does not account for
About BioElectronics Corporation
BioElectronics Corporation is the maker of unique inexpensive, drug-free, anti-inflammatory patches for a broad range of unmet soft tissue medical needs. The patches have an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti- inflammatory and pain relief therapy that, previously, has only been possible to obtain from large, facility-based equipment.
http://WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. BUYINS.NET has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 1,800,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like BUYINS.NET to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. BioElectronics Corporation has paid $995 per month to purchase data for information provided in six monthly reports. The data service can be cancelled at any time. This opinion contains forward- looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
BUYINS.NET and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
For more information visit http://www.bioelectronicscorp.com
|SOURCE BioElectronics Corporation|
Copyright©2008 PR Newswire.
All rights reserved